Global Biomarkers Technologies and Markets, 2018-2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Biomarkers: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering.
Current and projected biomarker market forecasts for the forecast period 2018 to 2023 are discussed. Products approved in the last three years by the U.S. Food and Drug Administration and products expected to be approved within the forecast period are projected. Due to the timing of this report, 2018 figures are estimated except where actual results have been reported.
This report includes an analysis of the leading and emerging competitors in the current worldwide biomarkers market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define specific product strategies that were employed. This report also assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care. Detailed profiles of the current market leaders, as well as companies with innovative products poised to advance within forecast period, are discussed.
In this report, market size and forecasts by segment, type, therapeutic area and geography from 2018 through 2023 have been provided. The study is arranged to offer an overview of the biomarkers market accompanied by product, company, geographic region or country. Virtually the entire globe is covered to include prevalent data for each disease subsegment. The report encompasses the use of major types of biomarkers for clinical and research applications. In addition, major applications that are being commercialized and developed by a wide range of companies, especially for drug discovery and development processes, are also considered. The application of biomarkers in the field of diagnostics and therapeutics for major indications such as cancer, immunological disorders, neurological disorders and others are also discussed.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Summary And Highlights
Chapter 3 Overview
Chapter 4 Regulatory Dynamics, Intellectual Property And Ethical Considerations
Chapter 5 Market Breakdown By Segment
Chapter 6 Market Breakdown By Therapeutic Area
Chapter 7 Market Breakdown By Type
Chapter 8 Market Breakdown By Region
Chapter 9 Competitive Landscape And Key Developments
Chapter 10 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/b5mqnz/global_biomarkers?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005600/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY OTHER SCIENCE SCIENCE
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/27/2018 10:46 AM/DISC: 09/27/2018 10:46 AM